These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 19277009)
21. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. Krishnan L; Sad S; Patel GB; Sprott GD J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050 [TBL] [Abstract][Full Text] [Related]
22. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Brown DM; Kamperschroer C; Dilzer AM; Roberts DM; Swain SL Cell Immunol; 2009; 257(1-2):69-79. PubMed ID: 19338979 [TBL] [Abstract][Full Text] [Related]
23. Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway. Cheng WF; Lee CN; Chang MC; Su YN; Chen CA; Hsieh CY Mol Ther; 2005 Nov; 12(5):960-8. PubMed ID: 15979942 [TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Gelbard A; Garnett CT; Abrams SI; Patel V; Gutkind JS; Palena C; Tsang KY; Schlom J; Hodge JW Clin Cancer Res; 2006 Mar; 12(6):1897-905. PubMed ID: 16551875 [TBL] [Abstract][Full Text] [Related]
25. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection. Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431 [TBL] [Abstract][Full Text] [Related]
26. Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B. Li J; Figueira SK; Vrazo AC; Binkowski BF; Butler BL; Tabata Y; Filipovich A; Jordan MB; Risma KA J Immunol; 2014 Jul; 193(2):519-28. PubMed ID: 24928990 [TBL] [Abstract][Full Text] [Related]
27. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373 [TBL] [Abstract][Full Text] [Related]
28. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells. Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983 [TBL] [Abstract][Full Text] [Related]
29. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. Graubert TA; DiPersio JF; Russell JH; Ley TJ J Clin Invest; 1997 Aug; 100(4):904-11. PubMed ID: 9259590 [TBL] [Abstract][Full Text] [Related]
30. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Williams NS; Engelhard VH J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456 [TBL] [Abstract][Full Text] [Related]
31. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity. Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142 [TBL] [Abstract][Full Text] [Related]
32. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes. Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816 [TBL] [Abstract][Full Text] [Related]
33. Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells. Laurin D; Marin V; Biagi E; Pizzitola I; Agostoni V; Gallot G; Vié H; Jacob MC; Chaperot L; Aspord C; Plumas J J Biomed Biotechnol; 2010; 2010():234540. PubMed ID: 20617141 [TBL] [Abstract][Full Text] [Related]
34. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021 [TBL] [Abstract][Full Text] [Related]
35. A therapy modality using recombinant IL-12 adenovirus plus E7 protein in a human papillomavirus 16 E6/E7-associated cervical cancer animal model. Ahn WS; Bae SM; Kim TY; Kim TG; Lee JM; Namkoong SE; Kim CK; Sin JI Hum Gene Ther; 2003 Oct; 14(15):1389-99. PubMed ID: 14577920 [TBL] [Abstract][Full Text] [Related]
36. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways. Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747 [TBL] [Abstract][Full Text] [Related]
37. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal. Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506 [TBL] [Abstract][Full Text] [Related]
38. Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack. Bergmann-Leitner ES; Abrams SI Cancer Immunol Immunother; 2000 Jul; 49(4-5):193-207. PubMed ID: 10941902 [TBL] [Abstract][Full Text] [Related]
39. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. Chakraborty M; Abrams SI; Camphausen K; Liu K; Scott T; Coleman CN; Hodge JW J Immunol; 2003 Jun; 170(12):6338-47. PubMed ID: 12794167 [TBL] [Abstract][Full Text] [Related]
40. Heat shock enhances the expression of cytotoxic granule proteins and augments the activities of tumor-associated antigen-specific cytotoxic T lymphocytes. Takahashi A; Torigoe T; Tamura Y; Kanaseki T; Tsukahara T; Sasaki Y; Kameshima H; Tsuruma T; Hirata K; Tokino T; Hirohashi Y; Sato N Cell Stress Chaperones; 2012 Nov; 17(6):757-63. PubMed ID: 22777894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]